We highly recommend enabling Javascript while using the BlackBoxRX site.

Tositumomab and Iodine I 131 Tositumomab

Hypersensitivity reactions, Anaphylaxis; Cyopenia

Hypersensitivity reactions, Anaphylaxis

  • Medications for the treatment of such reactions should be available for immediate use.


  • The majority of patients who receive this therapeutic regimen experience severe thrombocytopneia and neutropenia. Do not administer this regimen to patients with > 25% lymphoma marrow involvement and/or impaired bone marrow reverse

Pregnancy Category X

Special Requirements

  • This product contains a radioactive component and should be administered only by physicians and other health professionals qualified in training in the safe use and handling of radionuclides.
  • Physicians must be in the process or have been certified by Corixa Corporation in dose calculation and administration of this product.

Patient Counseling Information


Package Inserts


Additional Information

Updated January 2018